Action taken by Health Canada
To help mitigate the shortage of PEGASYS in Canada, Health Canada has permitted the exceptional, temporary importation and sale of US-authorized BESREMi by FORUS Therapeutics Inc. and added this product to the List of Drugs for Exceptional Importation and Sale.
Health Canada has worked with FORUS Therapeutics Inc. to prepare this alert for BESREMi. Health Canada is communicating this important safety information to healthcare professionals and Canadians via the Recalls and Safety Alerts Database on the Healthy Canadians Web Site. This communication update will be further distributed through the MedEffectTM e-Notice email notification system.